Glaxo goes head to head with UTC and both come out winners
Two A rated corporates went head to head in the euro corporate bond market on Monday as UK pharmaceuticals giant GlaxoSmithKline and US electrical systems manufacturer United Technologies Corp both launched triple-tranche deals, with two matching maturities involved in the €4.5bn of bonds.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: